OPINION The upcoming walk-in clinic for the Clinical Trials Information System (CTIS) hosted by the European Medicines Agency represents a crucial step towards enhancing transparency in clinical trials. This initiative,…
OPINION The upcoming 14th Industry Standing Group (ISG) meeting represents not just a gathering of industry players but a pivotal moment in the ongoing evolution of regulatory dialogue within the…
OPINION The upcoming bilateral meeting between the European Medicines Agency (EMA) and Medicines for Europe is not just a routine event; it signifies a critical intersection of regulatory oversight and…
OPINION The upcoming HMA-EMA meeting focused on AI presents a pivotal opportunity for healthcare stakeholders to come together and deliberate on the integration of artificial intelligence in medicine. As we…
OPINION The upcoming meeting of the industry stakeholder platform at the European Medicines Agency brings to light a crucial aspect of the pharmaceutical landscape: transparency in regulatory processes. As stakeholders…
OPINION The upcoming EMA/HMA multi-stakeholder forum on EudraVigilance and signal detection symbolizes a pivotal moment in the landscape of pharmacovigilance. As the complexities of drug safety monitoring continue to evolve,…
OPINION The upcoming workshop between notified bodies and expert panels is a crucial step in enhancing regulatory practices within the medical device sector. These collaborative engagements are essential for fostering…
OPINION The upcoming 20th industry stakeholder platform on the operation of EU pharmacovigilance marks a critical juncture for how safety monitoring of medicinal products is approached in the digital age.…
OPINION The upcoming SPOR and XEVMPD status update webinar is an essential event for stakeholders in the pharmaceutical and healthcare industries. It represents a critical opportunity for professionals to stay…
OPINION The upcoming Q&A clinic organized by the European Medicines Agency (EMA) on Substance, Organisation, and Referentials Management Services represents a pivotal opportunity for stakeholders in the pharmaceutical and regulatory…